HK1049629A1 - 用於口服或局部給藥的藥物組合物 - Google Patents

用於口服或局部給藥的藥物組合物 Download PDF

Info

Publication number
HK1049629A1
HK1049629A1 HK03101840.7A HK03101840A HK1049629A1 HK 1049629 A1 HK1049629 A1 HK 1049629A1 HK 03101840 A HK03101840 A HK 03101840A HK 1049629 A1 HK1049629 A1 HK 1049629A1
Authority
HK
Hong Kong
Prior art keywords
fatty acids
formulation
chor
esters
polyglycerol
Prior art date
Application number
HK03101840.7A
Other languages
English (en)
Chinese (zh)
Inventor
T‧安德雷塞克
M‧斯图啻利克
A‧维拉那
M‧斯圖啻利克
A‧杰戈罗夫
J‧斯图啻利克
A‧維拉那
V‧玛萨
A‧傑戈羅夫
J‧斯圖啻利克
V‧瑪薩
Original Assignee
伊瓦克斯药物公司
伊瓦克斯藥物公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10859192&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1049629(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 伊瓦克斯药物公司, 伊瓦克斯藥物公司 filed Critical 伊瓦克斯药物公司
Publication of HK1049629A1 publication Critical patent/HK1049629A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dispersion Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
HK03101840.7A 1999-08-17 2000-08-17 用於口服或局部給藥的藥物組合物 HK1049629A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9919288A GB2355656B (en) 1999-08-17 1999-08-17 Pharmaceutical compositions for oral and topical administration
GB9919288.2 1999-08-17
PCT/GB2000/003161 WO2001012229A1 (en) 1999-08-17 2000-08-17 Pharmaceutical compositions for oral and topical administration

Publications (1)

Publication Number Publication Date
HK1049629A1 true HK1049629A1 (zh) 2003-05-23

Family

ID=10859192

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03101840.7A HK1049629A1 (zh) 1999-08-17 2000-08-17 用於口服或局部給藥的藥物組合物

Country Status (40)

Country Link
US (1) US20070190132A1 (enExample)
EP (2) EP1334717B1 (enExample)
JP (2) JP2003507343A (enExample)
KR (2) KR100828747B1 (enExample)
CN (2) CN101406453A (enExample)
AR (2) AR025324A1 (enExample)
AT (2) ATE402691T1 (enExample)
AU (1) AU777740B2 (enExample)
BR (1) BR0013385A (enExample)
CA (2) CA2380951C (enExample)
CO (1) CO5380014A1 (enExample)
CY (1) CY1105318T1 (enExample)
CZ (2) CZ296170B6 (enExample)
DE (2) DE60018081T2 (enExample)
DK (2) DK1334717T3 (enExample)
EE (2) EE04954B1 (enExample)
EG (1) EG23994A (enExample)
ES (2) ES2311077T3 (enExample)
GB (1) GB2355656B (enExample)
HK (1) HK1049629A1 (enExample)
HR (1) HRP20020154B1 (enExample)
HU (1) HUP0203236A3 (enExample)
IL (4) IL158108A0 (enExample)
JO (1) JO2324B1 (enExample)
MX (1) MXPA02001631A (enExample)
NO (2) NO20020760L (enExample)
NZ (1) NZ517271A (enExample)
PE (1) PE20010636A1 (enExample)
PL (1) PL192769B1 (enExample)
PT (2) PT1210119E (enExample)
RU (2) RU2279894C2 (enExample)
SA (1) SA00210487B1 (enExample)
SG (1) SG143019A1 (enExample)
SI (1) SI1210119T1 (enExample)
SK (2) SK2482002A3 (enExample)
TN (1) TNSN00173A1 (enExample)
UA (2) UA72539C2 (enExample)
UY (1) UY26303A1 (enExample)
WO (1) WO2001012229A1 (enExample)
ZA (2) ZA200308221B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2355656B (en) * 1999-08-17 2004-04-07 Galena As Pharmaceutical compositions for oral and topical administration
FR2826261B1 (fr) * 2001-06-26 2005-03-25 Lmd Composition a usage topique comprenant un produit cytotoxique et son utilisation dans le traitement de l'alopeche
DE10154464B4 (de) * 2001-11-08 2005-10-20 Max Delbrueck Centrum Oral verabreichbare pharmazeutische Zubereitung umfassend liposomal verkapseltes Taxol
KR20030065831A (ko) * 2002-02-01 2003-08-09 주식회사 태평양 사이클로스포린을 함유한 지속 방출형 약학적 조성물
US7101576B2 (en) * 2002-04-12 2006-09-05 Elan Pharma International Limited Nanoparticulate megestrol formulations
US9101540B2 (en) 2002-04-12 2015-08-11 Alkermes Pharma Ireland Limited Nanoparticulate megestrol formulations
EP1935407A1 (en) * 2002-12-03 2008-06-25 Elan Pharma International Limited Low viscosity liquid dosage forms
JP4518042B2 (ja) * 2002-12-04 2010-08-04 日油株式会社 コエンザイムｑ１０を含有する水溶性組成物の製造方法
EP1582206A4 (en) * 2002-12-04 2010-09-22 Nisshin Pharma Inc WATER-SOLUBLE COMPOSITION WITH COENZYM Q10
SI1585548T1 (sl) 2002-12-09 2018-11-30 Abraxis Bioscience, Llc Sestave in metode odmerjanja farmakoloških sredstev
US6979672B2 (en) * 2002-12-20 2005-12-27 Polichem, S.A. Cyclosporin-based pharmaceutical compositions
TW200616681A (en) * 2004-10-05 2006-06-01 Recordati Ireland Ltd Lercanidipine capsules
US8236286B2 (en) * 2004-10-20 2012-08-07 Kao Corporation Liquid compositions for the oral cavity
WO2006091780A2 (en) * 2005-02-24 2006-08-31 Elan Pharma International Limited Nanoparticulate formulations of docetaxel and analogues thereof
BRPI0921654A2 (pt) * 2008-11-28 2016-02-10 Advance Holdings Ltd formulação farmacêutica
ES2403380T3 (es) * 2009-03-12 2013-05-17 Lectio Pharmaentwicklungs- Und Verwertungs Gmbh Formulación farmacéutica que comprende cetoprofeno y un éster de polioxialquileno de un hidroxiácido graso
KR101100933B1 (ko) * 2009-04-23 2012-01-02 한국기술교육대학교 산학협력단 솔더 볼 제거 장치
EP3274054A1 (en) * 2015-03-27 2018-01-31 Arch Personal Care Products, L.P. Viscosity building composition for personal care products
CN112426403B (zh) * 2020-12-09 2021-09-17 南京天纵易康生物科技股份有限公司 一种口腔溃疡凝胶及其制备方法和应用
TW202406566A (zh) * 2022-05-02 2024-02-16 日商中外製藥股份有限公司 包含用於與界面活性劑結合使用之胜肽化合物的組合物
CN119770478B (zh) * 2024-12-31 2025-12-19 美济生物医药(广州)有限公司 紫杉醇口服药物组合物、制剂及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
CZ288631B6 (cs) * 1996-01-18 2001-08-15 Galena, A. S. Léčivé přípravky s obsahem cyklosporinu
CZ288739B6 (cs) * 1996-08-01 2001-08-15 Galena, A. S. Cyklosporin obsahující léčivé přípravky
CZ283516B6 (cs) * 1996-09-12 1998-04-15 Galena A.S. Léčivé přípravky, zejména pro vnitřní aplikaci, ve formě samomikroemulgujících terapeutických systémů
NZ337316A (en) * 1997-03-12 2001-06-29 Abbott Lab Hydrophilic binary systems comprising cyclosporine, hydrophilic phase and a surfactant for the administration of cyclosporine
WO1998040051A1 (en) * 1997-03-12 1998-09-17 Abbott Laboratories Lipophilic binary systems for the administration of lipophilic compounds
NZ502569A (en) * 1997-07-29 2002-05-31 Upjohn Co Self-emulsifying formulation for lipophilic compounds comprising a mixture of diglyceride and monoglyceride in a ratio of 9:1 to 6:4
US6063762A (en) * 1997-12-05 2000-05-16 Chong Kun Dang Corp. Cyclosporin-containing microemulsion preconcentrate composition
US20030216303A1 (en) * 1998-03-06 2003-11-20 Michael Ambuhl Emulsion preconcentrates containing cyclosporin or a macrolide
GB2355656B (en) * 1999-08-17 2004-04-07 Galena As Pharmaceutical compositions for oral and topical administration

Also Published As

Publication number Publication date
MXPA02001631A (es) 2003-07-14
ES2237443T3 (es) 2005-08-01
HUP0203236A2 (hu) 2003-01-28
NO20020760L (no) 2002-04-16
DK1210119T3 (da) 2005-06-20
AR025324A1 (es) 2002-11-20
EE200300371A (et) 2003-10-15
IL148200A (en) 2007-12-03
CN101406453A (zh) 2009-04-15
EE04955B1 (et) 2008-02-15
EE04954B1 (et) 2008-02-15
HUP0203236A3 (en) 2004-06-28
HRP20020154B1 (en) 2006-07-31
KR20050095651A (ko) 2005-09-29
RU2003133451A (ru) 2005-04-20
SI1210119T1 (en) 2005-06-30
SG143019A1 (en) 2008-06-27
AU6461300A (en) 2001-03-13
KR20020059367A (ko) 2002-07-12
EG23994A (en) 2008-03-10
GB2355656B (en) 2004-04-07
JP2004238399A (ja) 2004-08-26
ZA200308221B (en) 2004-09-29
EP1210119B1 (en) 2005-02-09
AU777740B2 (en) 2004-10-28
UA75926C2 (en) 2006-06-15
CZ2002575A3 (cs) 2003-05-14
JP2003507343A (ja) 2003-02-25
GB2355656A (en) 2001-05-02
PT1334717E (pt) 2008-10-09
IL148200A0 (en) 2002-09-12
DE60018081T2 (de) 2006-01-05
ATE402691T1 (de) 2008-08-15
NO20020760D0 (no) 2002-02-15
US20070190132A1 (en) 2007-08-16
CY1105318T1 (el) 2010-03-03
ATE288766T1 (de) 2005-02-15
RU2279894C2 (ru) 2006-07-20
CZ296591B6 (cs) 2006-04-12
EE200200075A (et) 2003-04-15
SK2482002A3 (en) 2002-12-03
CA2380951A1 (en) 2001-02-22
PT1210119E (pt) 2005-05-31
SK286083B6 (sk) 2008-03-05
UA72539C2 (en) 2005-03-15
CA2380951C (en) 2010-03-23
PL353445A1 (en) 2003-11-17
DK1334717T3 (da) 2008-11-24
GB9919288D0 (en) 1999-10-20
EP1210119A1 (en) 2002-06-05
KR100828748B1 (ko) 2008-05-09
PE20010636A1 (es) 2001-06-02
EP1334717A3 (en) 2004-01-02
DE60322454D1 (de) 2008-09-11
KR100828747B1 (ko) 2008-05-09
NO20034778L (no) 2002-04-16
TNSN00173A1 (en) 2005-11-10
DE60018081D1 (de) 2005-03-17
CO5380014A1 (es) 2004-03-31
CZ296170B6 (cs) 2006-01-11
IL158108A (en) 2010-04-15
CA2452118A1 (en) 2001-02-22
EP1334717A2 (en) 2003-08-13
PL192769B1 (pl) 2006-12-29
AR043106A2 (es) 2005-07-20
WO2001012229A1 (en) 2001-02-22
JO2324B1 (en) 2005-09-12
BR0013385A (pt) 2002-05-07
NO20034778D0 (no) 2003-10-24
NZ517271A (en) 2004-02-27
RU2279895C2 (ru) 2006-07-20
CN1382061A (zh) 2002-11-27
EP1334717B1 (en) 2008-07-30
SA00210487B1 (ar) 2006-09-10
UY26303A1 (es) 2001-03-16
ZA200201315B (en) 2004-06-30
IL158108A0 (en) 2004-03-28
ES2311077T3 (es) 2009-02-01
HRP20020154A2 (en) 2003-12-31

Similar Documents

Publication Publication Date Title
HK1049629A1 (zh) 用於口服或局部給藥的藥物組合物
CN1124157C (zh) 药物组合物
CN1231208C (zh) 药物组合物
CN1313154C (zh) 在载体组合物中加溶难溶于水的活性成份的药物组合物及其制法
JP3420897B2 (ja) 医薬組成物
CN1353613A (zh) 药物组合物
CN1256939C (zh) 含有辅酶q10的微乳剂预浓缩物和微乳剂
WO2001032142A1 (en) Cyclosporin formulation
AU4500899A (en) Microemulsion preconcentrates containing a piperidine substance p antagonist
HK1133179A (en) Pharmaceutical compositions for oral and topical administration
CN101048137A (zh) 可自发分散的药物组合物
HK1068806B (en) Coenzyme q10 containing microemulsion preconcentrates and microemulsions
CN1361236A (zh) 玉米油和甘油的酯基转移产物及其制备方法
AU2006201547A1 (en) Pharmaceutical compostions for oral and topical administration
AU2003254754A1 (en) Pharmaceutical compositions for oral and topical administration
HK1084041A (en) Pharmaceutical compositions